Bloomberg
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Monday, November 16, 2026
Leo Pharma A/S postponed its planned initial public offering to a date after 2026, the company announced. The Danish pharmaceutical company had previously targeted a 2026 listing. No new target date for the IPO was provided.
Original reporting:
